Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

Compare

1.180

-0.090 (-7.09%)

At close: Feb 5, 2026, 4:00 PM EST

1.220

+0.040 (3.39%)

Pre-market: Feb 6, 2026, 6:12 AM EST

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	49.66	66.66	22.47	46.35	64.07	126.26
Short-Term Investments	66.29	171.3	147.56	92.01	22.68	26.01
Cash & Short-Term Investments	115.95	237.96	170.03	138.36	86.74	152.28
Cash Growth	-55.12%	39.95%	22.89%	59.50%	-43.04%	-43.95%
Receivables	2.33	3.47	1.01	0.03	0.01	0.4
Inventory	0.16	0.23	0.38	-	-	-
Prepaid Expenses	4.09	4.53	5.13	2.48	2.16	5.05
Total Current Assets	122.53	246.19	176.55	140.87	88.92	157.72
Property, Plant & Equipment	9.49	7.32	7.51	8.48	3.45	1.53
Goodwill	44.54	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	29.37	0.37	0.83	0.41	-	-
Total Assets	205.93	298.42	229.43	194.3	136.91	203.79
Accounts Payable	3.8	14.8	14.39	10.4	9.15	5.47
Accrued Expenses	11.98	29.27	15.87	11.49	11.88	29.14
Current Portion of Long-Term Debt	-	-	-	-	-	11.65
Current Portion of Leases	1.64	1.18	1.29	1.29	1.09	0.55
Current Unearned Revenue	4.3	-	-	-	-	-
Total Current Liabilities	21.72	45.25	31.55	23.17	22.12	46.81
Long-Term Debt	56.51	100.3	99.51	48.58	-	-
Long-Term Leases	6.8	4.6	5.27	5.42	1.19	0.61
Other Long-Term Liabilities	0.74	2.32	-	-	-	-
Total Liabilities	85.77	152.47	136.32	77.18	23.31	47.42
Common Stock	0.37	0.36	0.25	0.19	0.15	0.14
Additional Paid-In Capital	2,127	2,117	1,863	1,709	1,609	1,561
Retained Earnings	-2,002	-1,967	-1,767	-1,590	-1,488	-1,400
Treasury Stock	-5.19	-4.62	-2.89	-2.06	-7.52	-4.84
Comprehensive Income & Other	0.03	0.12	0.03	-0.43	-0.01	-0.01
Shareholders' Equity	120.16	145.95	93.11	117.12	113.6	156.37
Total Liabilities & Equity	205.93	298.42	229.43	194.3	136.91	203.79
Total Debt	64.95	106.07	106.06	55.29	2.28	12.81
Net Cash (Debt)	51	131.88	63.96	83.06	84.46	139.47
Net Cash Growth	-66.56%	106.19%	-23.00%	-1.66%	-39.44%	461.88%
Net Cash Per Share	0.14	0.41	0.29	0.50	0.58	1.26
Filing Date Shares Outstanding	363.4	361.49	246.24	188.73	149.59	143.56
Total Common Shares Outstanding	363.4	361.49	244.92	188.73	148.92	141.5
Working Capital	100.81	200.95	145	117.69	66.8	110.91
Book Value Per Share	0.33	0.40	0.38	0.62	0.76	1.11
Tangible Book Value	75.62	101.41	48.57	72.58	69.05	111.83
Tangible Book Value Per Share	0.21	0.28	0.20	0.38	0.46	0.79
Machinery	2.39	2.39	4.35	4	4.72	5.69
Leasehold Improvements	2.18	2.18	2.18	2.05	1.31	0.42

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q